| PUBCHEM ID |
121489809
|
| UNII |
6AHI0J4046
|
| Preferred Term |
1((4-BROMOPHENYL)METHYL)-1A,9B-DIHYDRO-1H-PHENANTHRO(9,10-B)AZIRINE
|
| CAS |
126420-93-7
|
| INCHIKEY |
FJWOOAVKTROJIP-TYABSZSSSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Brc1ccc(CN([C@@H]23)[C@@H]3c(cccc3)c3-c3c2cccc3)cc1
|
| Total Surface Area |
231,47
|
| Relative PSA |
0,0066963
|
| TPSA |
3,01
|
| cLogS |
-5,298
|
| MW |
362,269
|
| cLogP |
5,1467
|
| H-Acceptors |
1
|
| H-Donors |
0
|
| Ro5 violations |
1
|
| Druglikeness |
0,70064
|
| DrugScore |
0,11526374469068
|
| Mutagenic |
high
|
| Tumorigenic |
low
|
| Reproductive Effective |
high
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2+
|
| Caco-2 Permeability II |
1,7705
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,628
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,2072
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5826
|
| Carcinogenicity (Three-class) |
Non-required
|
